Tianjin First Central Hospital
Clinical trials sponsored by Tianjin First Central Hospital, explained in plain language.
-
Experimental shot aims to clear Hard-to-Treat HPV strains
Disease control Not yet recruitingThis study tests an experimental injection called BBM-C101 in 200 people with persistent HPV16 or HPV18 infection and low-grade precancerous lesions of the cervix, vulva, vagina, or anus. Participants receive four shots under the skin over three weeks. The trial monitors safety a…
Phase: NA • Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Targeted antibody may boost brain cancer treatment after incomplete surgery
Disease control Not yet recruitingThis phase 2 trial tests whether adding nimotuzumab—an antibody that blocks a protein called EGFR—to the standard Stupp regimen (temozolomide plus radiotherapy) can improve outcomes for adults with glioblastoma that was not fully removed by surgery. Participants must have EGFR-po…
Phase: PHASE2 • Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Real-world test of adebrelimab combo for tough cancers
Knowledge-focused Not yet recruitingThis study will observe 300 people with advanced lung or gastrointestinal cancers who receive adebrelimab combined with other treatments. Researchers will track side effects and how well the cancer responds. It is a real-world study, meaning it watches what happens in regular med…
Sponsor: Tianjin First Central Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:13 UTC